Fatty acids kill cancer cells starved of arginine

Tumors create their own environment in which many nutrients are scarce. Researchers focused on pancreatic cancer and investigated what happens when those cells receive too little arginine, an amino acid that is normally abundant in healthy tissue. The study, published in eLife, shows that arginine limitation in the tumor triggers a cascade that disrupts fatty acid production.

Normally, cells produce their own fatty acids through a molecule called SREBP1, a transcription factor that regulates the synthesis of saturated and monounsaturated fats. Under arginine limitation, SREBP1 becomes less active, partly through the amino acid sensor protein GCN2. As a result, cancer cells can no longer maintain balance in their cell membranes: they cannot produce enough saturated fatty acids to offset an excess of polyunsaturated fatty acids (PUFAs). This imbalance leads to a form of cell death called ferroptosis, in which oxidative damage to lipids destroys the cell.

A weakness that can be exploited

Pancreatic cancer is notoriously difficult to treat. The discovery that these tumors are vulnerable to PUFAs when already arginine-deprived offers a potential intervention point. Experiments with pancreatic cancer in cell culture and in mice showed that exposure to polyunsaturated fats did indeed cause cell death under tumor-like conditions.

This remains a laboratory observation, not a clinical therapy. Whether the mechanism also operates in people with pancreatic cancer has not been demonstrated. Additionally, raising PUFA levels specifically within tumors without affecting healthy tissues is technically challenging.

Metabolism as the Achilles heel of cancer

The study fits within a broader research movement examining metabolic vulnerabilities of cancer cells. Poorly perfused tumors have different metabolic profiles than healthy cells, and those differences are also weak points. For longevity research, this is relevant: similar metabolic dysregulation plays a role in normal cellular aging and in senescent cells that secrete inflammatory molecules.

Read the original article